Back

Circulating ectoenzyme CD38 is associated with diastolic dysfunction in subjects with metabolic syndrome: a population-based cross-sectional study

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Lipids, inflammation, and cardiometabolic risk Cardiomyopathies ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Stefano Ministrini

University of Zurich, Zurich (Switzerland)

6 More presentations in this session

Presentation thumbnail
Investigating the heart-liver-axis in metabolic dysfunction-associated steatohepatitis and acute myocardial infarction
Mr A. Jacobs (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Tumor necrosis factor-α deficiency attenuates obesity and mitigates the severity of CpcPH-HFpEF in mouse models
Miss L. Zimmermann (Cologne, DE)
Abstract Slides
Presentation thumbnail
Pro-inflammatory lipid profile in isolated adipocyte cultures from patients with congestive heart failure: a possible role in the development of cardiac cachexia.
Doctor A. Bongrani (Parma, IT)
Abstract Slides
Presentation thumbnail
Lp(a) impairs NK cell function potentially contributes to impaired immunity and increased cardiovascular disease risk
Doctor Y. Baumer (US)
Abstract Slides
Presentation thumbnail
Inflammatory burden, but not genetic variation, predicts attenuated LDL cholesterol reduction after ST-elevation myocardial infarction
Mr I. Simanauskas (Kaunas, LT)
Abstract Slides

Access the full session

Session thumbnail
Lipids, inflammation, and cardiometabolic risk

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Serum biomarkers in the diagnosis of left ventricular diastolic dysfunction in visceral obesity
29 June 2021
thumbnail
Congress Presentation
The effect of CD38 inhibition in age-associated vascular dysfunction
31 August 2024
thumbnail
ESC Journals
A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment
2 March 2021
thumbnail
Congress Presentation
HDAC6 inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources